泰加塞罗德刺激5-HT4 血清素受体在孤立的人类心房
Christin Hesse1, Joachim Neumann1, Valerie Compan2
1Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany.
International journal of molecular sciences
|October 26, 2024
概括
泰加塞罗德是一种用于肠道疾病的5-HT4受体激动剂,可刺激人类心脏心房5-HT4受体. 这种作用涉及循环腺单酸盐 (cAMP) 依赖的途径,影响心脏收缩性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 泰加塞罗德是一种5-HT4 血清素受体激动剂,用于治疗肠道疾病.
- 5-HT4受体在心脏功能中的作用尚未完全理解.
- 研究 tegaserod 对心脏的影响对于理解其更广泛的生理影响至关重要.
研究的目的:
- 为了确定泰格塞罗德是否刺激人类心脏心房5-HT4受体.
- 为了阐明涉及到 tegaserod 的心脏影响的信号通路.
- 描述 tegaserod 在心脏组织中的无otropic 和慢性otropic 作用.
主要方法:
- 使用过度表达人类5-HT4受体 (5-HT4-TG) 的转基因小鼠和野生型 (WT) littermates.
- 进行了西方斑点分析以确认受体表达水平.
- 研究了孤立的人类心房准备剂 (HAPs),以评估 tegaserod 对收缩性和对其他药物的反应的影响.
主要成果:
- 泰加塞罗德在5-HT4-TG小鼠心脏中表现出度和时间依赖的积极的内和长作用,但在WT心脏中没有.
- 西方斑点证实在5-HT4-TG小鼠中的5-HT4受体表达显著更高.
- 在人类心房制剂中,tegaserod增加了收缩力,减少了放松时间,增加了紧张发展速度,充当了部分激动剂.
- 这些效应被西洛斯塔胺增强,并被5-HT4抗剂GR 125487减弱,这表明一种依赖于cAMP的机制.
结论:
- 泰加塞罗德可以刺激人类心脏心房5-HT4受体.
- 该机制涉及循环腺单酸盐 (cAMP) 依赖的途径.
- 泰加塞罗德在心脏5-HT4受体上表现出部分激素活性,影响收缩性.
相关概念视频
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...